Nurosym’s device is equally user-friendly, making use of a similar device to stimulate the vagus nerve—which runs between the ...

It completely altered my life,” says one woman who ate a single THC gummy before watching a movie at home. “My surroundings ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

Simone and Malcolm Collins started out with two elite degrees, a startup and a progressive vision for the future. Now, ...

Net sales of Cobenfy, whose success is imperative for Bristol Myers, totaled $27 million in the first quarter, handily ...

Good day, and welcome to the Bristol Myers Squibb First Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there ...

Bristol-Myers Squibb Company's Q1 2025 earnings reveal revenue decline but EPS growth. Click to discover BMY challenges, ...

A forgotten bestseller that deserves a BookTok revival, 'I Never Promised You a Rose Garden' is a bold, lyrical portrayal of ...

Anavex Life Sciences Corp. ("Anavex" or the "Company") (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments ...

Real-time index price for Nasdaq US MD Cap Telecom Index USD (NQTI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...

For some patients, simulated situations controlled by therapists may be less overwhelming than real-life exposure therapy.

Minerva Neurosciences Inc. company and executive profile by Barron's. View the latest NERV company infomation and executive bios.